Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston makes strides with carotid stent study:

This article was originally published in Clinica

Executive Summary

Boston Scientific has completed the enrolment phase of a clinical trial to assess stenting together with embolic protection in the treatment of carotid artery disease. The single-arm study, called BEACH, is a prospective, non-randomised trial enrolling 747 patients at 47 sites across the US. It is testing Boston's FilterWire EZ embolic protection system and its carotid Wallstent monorail endoprosthesis in patients who are at high risk for traditional surgery - ie carotid endarterectomy. Both devices are commercially available in Europe and other markets outside the US.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT057089

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel